Detection of antibodies specific to herpes type 1 only
1 - 2 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
For more information, please view the literature below.
Herpes Simplex Virus: Genital, Neonatal, Encephalitis, and Other HSV Infections
Serum
0.5 mL
0.2 mL
Red-top tube or gel-barrier tube
Refrigerate.
Temperature
Period
Room temperature
2 days
Refrigerated
7 days
Frozen
98 days at -25°C to -10°C
Qualititative detection of IgG antibodies specific to HSV type 1 infection; confirm or rule out possible infection with herpes simplex type 1 virus in prenatal patients. In a patient with no history of lesion disease, a positive result for this test may be indicative that the primary infection was asymptomatic. Once infected by HSV, it is possible for a patient to shed virus without the development of lesions (asymptomatic shedding). This test does not indicate the site of HSV infection. The magnitude of the Index Value is not indicative of the amount of antibody present in the patient sample.
Chemiluminescent immunoassay (CLIA)
Negative: <0.91 index
There is a considerable homology between HSV-1 and HSV-2 antigens, so that antibodies formed against either virus are highly cross-reactive. This assay is based on purified recombinant glycoprotein G-1 and is specific for type 1 antibodies. Moreover, this assay is highly sensitive and specific and will not detect antibodies to HSV-2.
Test is set up and reported Monday through Friday.
